239 related articles for article (PubMed ID: 30527228)
1. Target volume selection and delineation (T and N) for primary radiation treatment of oral cavity, oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma.
Grégoire V; Grau C; Lapeyre M; Maingon P
Oral Oncol; 2018 Dec; 87():131-137. PubMed ID: 30527228
[TBL] [Abstract][Full Text] [Related]
2. Target delineation for postoperative treatment of head and neck cancer.
Evans M; Beasley M
Oral Oncol; 2018 Nov; 86():288-295. PubMed ID: 30409314
[TBL] [Abstract][Full Text] [Related]
3. Analysis of lymphatic metastasis and progression patterns for clinical target volume (CTV) definition in head and neck squamous cell carcinoma (HNSCC).
Pouymayou B; Koechli C; Balermpas P; Guckenberger M; Unkelbach J
Acta Oncol; 2019 Oct; 58(10):1519-1522. PubMed ID: 31364898
[No Abstract] [Full Text] [Related]
4. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.
Grégoire V; Evans M; Le QT; Bourhis J; Budach V; Chen A; Eisbruch A; Feng M; Giralt J; Gupta T; Hamoir M; Helito JK; Hu C; Hunter K; Johansen J; Kaanders J; Laskar SG; Lee A; Maingon P; Mäkitie A; Micciche' F; Nicolai P; O'Sullivan B; Poitevin A; Porceddu S; Składowski K; Tribius S; Waldron J; Wee J; Yao M; Yom SS; Zimmermann F; Grau C
Radiother Oncol; 2018 Jan; 126(1):3-24. PubMed ID: 29180076
[TBL] [Abstract][Full Text] [Related]
5. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
6. Selective nodal irradiation for head and neck cancer using intensity-modulated radiotherapy: application of RTOG consensus guidelines in routine clinical practice.
Nangia S; Chufal KS; Tyagi A; Bhatnagar A; Mishra M; Ghosh D
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):146-53. PubMed ID: 19553034
[TBL] [Abstract][Full Text] [Related]
7. Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.
Spencer CR; Gay HA; Haughey BH; Nussenbaum B; Adkins DR; Wildes TM; DeWees TA; Lewis JS; Thorstad WL
Cancer; 2014 Dec; 120(24):3994-4002. PubMed ID: 25143048
[TBL] [Abstract][Full Text] [Related]
8. Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
van den Bosch S; Dijkema T; Verhoef LC; Zwijnenburg EM; Janssens GO; Kaanders JH
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):766-74. PubMed ID: 26972649
[TBL] [Abstract][Full Text] [Related]
9. Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma.
Due AK; Vogelius IR; Aznar MC; Bentzen SM; Berthelsen AK; Korreman SS; Kristensen CA; Specht L
Strahlenther Onkol; 2012 Aug; 188(8):671-6. PubMed ID: 22580623
[TBL] [Abstract][Full Text] [Related]
10. Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy.
Cardenas CE; Mohamed ASR; Tao R; Wong AJR; Awan MJ; Kuruvila S; Aristophanous M; Gunn GB; Phan J; Beadle BM; Frank SJ; Garden AS; Morrison WH; Fuller CD; Rosenthal DI
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):532-540. PubMed ID: 28258898
[TBL] [Abstract][Full Text] [Related]
11. Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer.
Apolle R; Appold S; Bijl HP; Blanchard P; Bussink J; Faivre-Finn C; Khalifa J; Laprie A; Lievens Y; Madani I; Ruffier A; de Ruysscher D; van Elmpt W; Troost EGC
Acta Oncol; 2019 Oct; 58(10):1378-1385. PubMed ID: 31271079
[No Abstract] [Full Text] [Related]
12. Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update.
Biau J; Lapeyre M; Troussier I; Budach W; Giralt J; Grau C; Kazmierska J; Langendijk JA; Ozsahin M; O'Sullivan B; Bourhis J; Grégoire V
Radiother Oncol; 2019 May; 134():1-9. PubMed ID: 31005201
[TBL] [Abstract][Full Text] [Related]
13. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer.
Chen AM; Farwell DG; Luu Q; Chen LM; Vijayakumar S; Purdy JA
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1423-9. PubMed ID: 20656416
[TBL] [Abstract][Full Text] [Related]
14. Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer.
Johansen S; Norman MH; Dale E; Amdal CD; Furre T; Malinen E; Evensen JF
Radiat Oncol; 2017 May; 12(1):87. PubMed ID: 28545588
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
16. [Selection and delineation of lymph node target volumes in head and neck neoplasms].
Grégoire V; Daisne JF; Bauvois C; Coche E; Duprez T; Hamoir M; Reychler H
Cancer Radiother; 2001 Oct; 5(5):614-28. PubMed ID: 11715313
[TBL] [Abstract][Full Text] [Related]
17. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
[TBL] [Abstract][Full Text] [Related]
18. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines.
Grégoire V; Ang K; Budach W; Grau C; Hamoir M; Langendijk JA; Lee A; Le QT; Maingon P; Nutting C; O'Sullivan B; Porceddu SV; Lengele B
Radiother Oncol; 2014 Jan; 110(1):172-81. PubMed ID: 24183870
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of CT-based image-biomarkers for head and neck cancer patients treated with definitive (chemo-)radiation.
Zhai TT; Langendijk JA; van Dijk LV; Halmos GB; Witjes MJH; Oosting SF; Noordzij W; Sijtsema NM; Steenbakkers RJHM
Oral Oncol; 2019 Aug; 95():178-186. PubMed ID: 31345388
[TBL] [Abstract][Full Text] [Related]
20. Delineating neck targets for intensity-modulated radiation therapy of head and neck cancer.
David MB; Eisbruch A
Front Radiat Ther Oncol; 2011; 43():255-270. PubMed ID: 21625157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
